Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/24/2026

Intravenous Thiamine Dosing and Safety Guidelines

Dosing Recommendations

  • Maximum therapeutic dose – Up to 500 mg IV three times daily (total 1500 mg/day) is recommended for acute encephalopathy of uncertain cause, including Wernicke encephalopathy. Grade B recommendation (strong consensus, moderate evidence). 1
  • Deficiency‑confirmed or high‑suspicion cases – 200 mg IV three times daily is advised. 1
  • Patients at risk of deficiency – 100 mg IV three times daily is appropriate. 1
  • General ICU/ emergency admission – 100–300 mg IV per day for 3–4 days without hesitation. 3
  • Refeeding‑syndrome protocol – Administer 300 mg IV thiamine before nutrition initiation, then 200–300 mg IV daily for at least three additional days. 2
  • Standard parenteral nutrition (maintenance) – Minimum 2.5 mg IV thiamine per day for adults (maintenance, not therapeutic). 3

Safety and Toxicity

  • Upper limit – No established tolerable upper intake level; excess thiamine is rapidly excreted in urine. 1
  • Adverse effects at high doses – Doses > 400 mg IV may cause nausea, anorexia, and mild ataxia; rare cases of anaphylaxis have been reported with very high IV doses. 2

Route Selection

  • IV preferred when any of the following are present: acute disease, suspected inadequate intake (even short‑term), severe deficiency symptoms, or alcohol‑related gastritis that may impair oral absorption. Grade B recommendation. 1
  • Oral adequate for chronic deficiency without acute illness and for maintenance therapy after acute IV treatment. 2

Pediatric Dosing (Weight‑Based)

Population Recommended IV Thiamine Dose
Preterm infants 0.35–0.50 mg /kg / day
Term infants 0.35–0.50 mg /kg / day
Children / adolescents ≈ 1.2 mg / day

These pediatric doses are substantially lower than adult therapeutic regimens and should not be extrapolated to adult emergencies. 4

Clinical Practice Recommendations

  • Empiric treatment – Do not delay IV thiamine in emergency or ICU settings while awaiting laboratory confirmation; the risk‑benefit ratio strongly favors immediate empiric therapy. Grade B. 3
  • Oral supplementation caution – Do not rely on oral thiamine in acute illness, malabsorption states, or alcohol‑use disorder; IV administration is preferred. 3
  • Monitoring – Observe for rare anaphylactic reactions when using high‑dose IV thiamine, although the risk is minimal. 2
  • Dose distinction – Clearly differentiate maintenance parenteral nutrition doses (≈ 2.5 mg/day) from therapeutic emergency doses (up to 1500 mg/day) to avoid under‑ or overdosing. 3